New York State Common Retirement Fund Sells 10,135 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

New York State Common Retirement Fund reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 13.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,945 shares of the biotechnology company’s stock after selling 10,135 shares during the quarter. New York State Common Retirement Fund’s holdings in Axon Enterprise were worth $17,294,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. BKM Wealth Management LLC bought a new position in Axon Enterprise in the fourth quarter worth about $32,000. Key Financial Inc raised its holdings in Axon Enterprise by 367.6% in the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares in the last quarter. Lindbrook Capital LLC raised its holdings in Axon Enterprise by 43.3% in the fourth quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock worth $44,000 after purchasing an additional 52 shares in the last quarter. Rakuten Securities Inc. bought a new position in Axon Enterprise in the fourth quarter worth about $48,000. Finally, Provence Wealth Management Group bought a new position in Axon Enterprise in the third quarter worth about $80,000. 79.08% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

AXON has been the subject of a number of recent research reports. Morgan Stanley boosted their target price on shares of Axon Enterprise from $285.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a report on Thursday, April 11th. StockNews.com downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating in a report on Thursday, March 14th. Barclays upped their price objective on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. Finally, TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $314.91.

Axon Enterprise Trading Up 0.6 %

Axon Enterprise stock opened at $308.23 on Monday. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87. The stock’s 50 day simple moving average is $304.22 and its two-hundred day simple moving average is $262.21. The firm has a market cap of $23.26 billion, a PE ratio of 134.01 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Analysts anticipate that Axon Enterprise, Inc. will post 2.44 earnings per share for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.